Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Early-stage Breast Cancer
Interventions: DRUG: Granulocyte Colony-Stimulating Factor (G-CSF)|DRUG: Omission of Granulocyte Colony-Stimulating Factor (G-CSF)
Sponsor: Ottawa Hospital Research Institute